Pediatric Oncology

Cardiotoxicity

Questions discussed in this category

How would you manage metastatic alveolar soft part sarcoma in an young patient failing TKI?

How do you incorporate PD-L1 blockade?

1 Answer available

Papers discussed in this category

The Lancet. Oncology, 2019-06

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.

Related Topics in Pediatric Oncology